Cunningham D - Search Results

1

Targeting the PI3K-AKT-mTOR signaling network in cancer.

Khan KH, Yap TA, Yan L, Cunningham D. Khan KH, et al. Among authors: cunningham d. Chin J Cancer. 2013 May;32(5):253-65. doi: 10.5732/cjc.013.10057. Chin J Cancer. 2013. PMID: 23642907 Free PMC article. Review.

2

Inhibition of Kirsten-ras expression in human colorectal cancer using rationally selected Kirsten-ras antisense oligonucleotides.

Ross PJ, George M, Cunningham D, DiStefano F, Andreyev HJ, Workman P, Clarke PA. Ross PJ, et al. Among authors: cunningham d. Mol Cancer Ther. 2001 Nov;1(1):29-41. Mol Cancer Ther. 2001. PMID: 12467236

3

Current treatment strategies in elderly patients with metastatic colorectal cancer.

Arkenau HT, Chua YJ, Cunningham D. Arkenau HT, et al. Among authors: cunningham d. Clin Colorectal Cancer. 2007 May;6(7):508-15. doi: 10.3816/ccc.2007.n.016. Clin Colorectal Cancer. 2007. PMID: 17553199 Review.

4

The role of epidermal growth factor receptor-targeted antibody therapy in previously treated colorectal cancer.

Watkins D, Cunningham D. Watkins D, et al. Among authors: cunningham d. Clin Colorectal Cancer. 2007 Oct;6 Suppl 2:S47-52. doi: 10.3816/ccc.2007.s.002. Clin Colorectal Cancer. 2007. PMID: 18021487 Review.

5

Epidermal growth factor receptor inhibitor-related skin toxicity: mechanisms, treatment, and its potential role as a predictive marker.

Bianchini D, Jayanth A, Chua YJ, Cunningham D. Bianchini D, et al. Among authors: cunningham d. Clin Colorectal Cancer. 2008 Jan;7(1):33-43. doi: 10.3816/CCC.2008.n.005. Clin Colorectal Cancer. 2008. PMID: 18279575 Review.

6

Insulin-like growth factor 1 receptor targeted therapeutics: novel compounds and novel treatment strategies for cancer medicine.

Hewish M, Chau I, Cunningham D. Hewish M, et al. Among authors: cunningham d. Recent Pat Anticancer Drug Discov. 2009 Jan;4(1):54-72. doi: 10.2174/157489209787002515. Recent Pat Anticancer Drug Discov. 2009. PMID: 19149688 Review.

7

Treatment in advanced colorectal cancer: what, when and how?

Chau I, Cunningham D. Chau I, et al. Among authors: cunningham d. Br J Cancer. 2009 Jun 2;100(11):1704-19. doi: 10.1038/sj.bjc.6605061. Epub 2009 May 12. Br J Cancer. 2009. PMID: 19436303 Free PMC article. Review.

8

Colorectal cancer.

Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, Starling N. Cunningham D, et al. Lancet. 2010 Mar 20;375(9719):1030-47. doi: 10.1016/S0140-6736(10)60353-4. Lancet. 2010. PMID: 20304247 Review.

9

Targeted therapies as adjuvant treatment for early-stage colorectal cancer: first impressions and clinical questions.

Banerjee S, Cunningham D. Banerjee S, et al. Among authors: cunningham d. Clin Colorectal Cancer. 2010 Jun;9 Suppl 1:S28-35. doi: 10.3816/CCC.2010.s.004. Clin Colorectal Cancer. 2010. PMID: 20630848 Review.

10

Predictive and prognostic biomarkers for targeted therapy in metastatic colorectal cancer.

Asghar U, Hawkes E, Cunningham D. Asghar U, et al. Among authors: cunningham d. Clin Colorectal Cancer. 2010 Dec;9(5):274-81. doi: 10.3816/CCC.2010.n.040. Clin Colorectal Cancer. 2010. PMID: 21208841 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,206 results

Search Page